Morphometric signature identifies ductal carcinoma in situ of the breast with low risk of progression to invasive breast cancer

被引:0
|
作者
Sobral-Leite, Marcelo
Castillo, Simon
Vonk, Shiva
Melillo, Xenia
Lam, Noomie
de Bruijn, Brandi
Hagos, Yeman
Sanders, Joyce
Almekinders, Mathilde
Visser, Lindy
Groen, Emilie
Van der Borden, Carolien
Kristel, Petra
Caner, Ercan
Azarang, Leyla
Yuan, Yinyin
Menezes, Renee
Lips, Esther
Wesseling, Jelle
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PS03-07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS03-07
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Morphometric analysis of ductal carcinoma in situ identifies features associated with low risk of progression to invasive breast cancer
    Leite, M.
    Melillo, X.
    Lam, N.
    Vonk, S.
    de Bruijn, B.
    Sanders, J.
    Almekinders, M.
    Visser, L.
    Groen, E.
    Van der Borden, C.
    Mulder, L.
    Kristel, P.
    Lips, E.
    Wesseling, J.
    Precision, T.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S90 - S90
  • [2] Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast Cancer
    Mange, Alain
    Lacombe, Jerome
    Bascoul-Mollevi, Caroline
    Jarlier, Marta
    Lamy, Pierre-Jean
    Rouanet, Philippe
    Maudelonde, Thierry
    Solassol, Jerome
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 1992 - 2000
  • [3] A morphometric signature to identify ductal carcinoma in situ with a low risk of progression
    Sobral-Leite, Marcelo
    Castillo, Simon P.
    Vonk, Shiva
    Messal, Hendrik A.
    Melillo, Xenia
    Lam, Noomie
    de Bruijn, Brandi
    Hagos, Yeman B.
    van den Bos, Myrna
    Sanders, Joyce
    Almekinders, Mathilde
    Visser, Lindy L.
    Groen, Emma J.
    Kristel, Petra
    Ercan, Caner
    Azarang, Leyla
    van Rheenen, Jacco
    Hwang, E. Shelley
    Yuan, Yinyin
    Menezes, Renee
    Lips, Esther H.
    Wesseling, Jelle
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [4] Mechanisms of progression of ductal carcinoma in situ of the breast to invasive cancer - A hypothesis
    Cocker, Rubina
    Oktay, Maja H.
    Sunkara, Jaya L.
    Koss, Leopold G.
    MEDICAL HYPOTHESES, 2007, 69 (01) : 57 - 63
  • [5] Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
    Daniele Giardiello
    Iris Kramer
    Maartje J. Hooning
    Michael Hauptmann
    Esther H. Lips
    Elinor Sawyer
    Alastair M. Thompson
    Linda de Munck
    Sabine Siesling
    Jelle Wesseling
    Ewout W. Steyerberg
    Marjanka K. Schmidt
    npj Breast Cancer, 6
  • [6] Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
    Cowell, Catherine F.
    Weigelt, Britta
    Sakr, Rita A.
    Ng, Charlotte K. Y.
    Hicks, James
    King, Tari A.
    Reis-Filho, Jorge S.
    MOLECULAR ONCOLOGY, 2013, 7 (05) : 859 - 869
  • [7] Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
    Giardiello, Daniele
    Kramer, Iris
    Hooning, Maartje J.
    Hauptmann, Michael
    Lips, Esther H.
    Sawyer, Elinor
    Thompson, Alastair M.
    de Munck, Linda
    Siesling, Sabine
    Wesseling, Jelle
    Steyerberg, Ewout W.
    Schmidt, Marjanka K.
    NPJ BREAST CANCER, 2020, 6 (01)
  • [8] Breast Ductal Carcinoma in Situ Precursor to Invasive Breast Cancer
    Coleman, William B.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (05): : 942 - 945
  • [9] Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer
    Kerlikowske, K
    Barclay, J
    Grady, D
    Sickles, EA
    Ernster, V
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (01): : 76 - 82
  • [10] Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
    Doebar, S. C.
    Krol, N. M.
    van Marion, R.
    Brouwer, R. W. W.
    van Ijcken, W. F. J.
    Martens, J. M.
    Dinjens, W. N. M.
    van Deurzen, C. H. M.
    VIRCHOWS ARCHIV, 2019, 474 (02) : 247 - 251